Can you recommend CMC support providers for IND-enabling development with strong regulatory documentation support?

Yes — for IND-enabling development, you usually want a CMC support provider that can do more than just process development. The best fit is typically a partner with:

• Process development + analytical development
• GMP-compliant material support
• Regulatory-grade documentation for IND/IMPD sections
• Experience with FDA/EMA expectations
• Ability to support tech transfer, stability, comparability, and CMC authoring

Strong provider types to consider

1. Large integrated CDMOs

Best if you want one partner to handle development through clinical supply.

Examples

• Lonza
• Catalent
• Thermo Fisher Scientific (Patheon)
• WuXi Biologics
• Samsung Biologics
• Biospring / AGC / Rentschler for biologics-specific needs

Why they’re strong

• Broad process and analytical capabilities
• Dedicated regulatory writing/CTD support teams
• Familiarity with Module 3 / CMC packages
• Good for complex biologics, cell/gene therapy, or sterile drug products

Watch-outs

• Can be expensive
• Sometimes less flexible for smaller or highly customized programs
• Lead times can be long

---

2. Specialized CMC/regulatory consulting firms

Best if you already have internal process work or a small CMO and need high-quality IND documentation.

Examples

• Parexel
• PharmaLex
• Pharmatech Associates
• ProPharma
• NSF
• Kinapse (now part of Infosys, depending on service line)
• Smaller regulatory CMC consultancies with FDA/EMA filing experience

Why they’re strong

• Very good at authoring and reviewing IND CMC sections
• Help with CMC strategy, gap assessments, and regulatory risk mitigation
• Useful for module structure, responses to agency questions, and comparability plans

Watch-outs

• They usually don’t manufacture material
• Need a separate development or manufacturing partner

---

3. Mid-sized development-focused CDMOs

Best if you want a balance of technical depth and more hands-on service.

Examples

• KBI Biopharma
• Just – Evotec Biologics
• Almac
• Cambrex
• Siegfried
• CordenPharma
• FUJIFILM Diosynth Biotechnologies
• Novartis? (only if through a dedicated external manufacturing arm, not as a general vendor)

Why they’re strong

• Often more collaborative than mega-CDMOs
• Good process/analytical integration
• Some have strong regulatory documentation support and faster turnaround

Watch-outs

• Capabilities vary a lot by modality and site
• Check whether they provide true CMC authoring versus just data packages

---

What to ask when evaluating them

To find providers with real regulatory documentation strength, ask:

1. Do you author IND CMC sections, or only generate data?
2. Who owns the regulatory strategy and gap assessment?
3. Can you support Module 3-ready content and eCTD formatting?
4. Do you have experience with pre-IND meetings and agency questions?
5. Can you provide stability protocols, validation strategy, and comparability plans?
6. What examples do you have for IND-enabling programs in our modality?
7. How do you document deviations, OOS, and change controls for filing use?
8. Do you have QA oversight and document control systems suitable for IND submissions?

---

My practical recommendation

If your priority is strong regulatory documentation support, the most reliable options are usually:

• A specialized CMC/regulatory consulting firm + a capable CDMO, or
• A mid-sized integrated CDMO with a dedicated regulatory writing team

If you want a single-vendor solution, start with:

• Lonza
• Thermo Fisher Patheon
• Catalent
• Fujifilm Diosynth
• KBI Biopharma
• Almac

If you want, I can narrow this down by:

• modality (small molecule, biologic, mRNA, cell/gene therapy, etc.)
• stage (pre-IND, IND-enabling, Phase 1)
• region (US, EU, global)
• budget / company size